58 related articles for article (PubMed ID: 9849753)
21. Pediatric clinical trial experience: government, child, parent and physician's perspective.
Salazar JC
Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
[TBL] [Abstract][Full Text] [Related]
22. Anesthetic considerations for the pediatric oncology patient--part 1: a review of antitumor therapy.
Latham GJ; Greenberg RS
Paediatr Anaesth; 2010 Apr; 20(4):295-304. PubMed ID: 20470332
[TBL] [Abstract][Full Text] [Related]
23. Antibody-based targeted radiation to pediatric tumors.
Modak S; Cheung NK
J Nucl Med; 2005 Jan; 46 Suppl 1():157S-63S. PubMed ID: 15653664
[TBL] [Abstract][Full Text] [Related]
24. Developing new agents for the treatment of childhood cancer.
Kurmasheva R; Morton C; Houghton PJ
Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407
[TBL] [Abstract][Full Text] [Related]
25. Preventing organ-specific chemotherapy toxicity.
Ginsberg JP; Womer RB
Eur J Cancer; 2005 Nov; 41(17):2690-700. PubMed ID: 16243514
[TBL] [Abstract][Full Text] [Related]
26. Radiation oncology research in the cancer and leukemia group B.
Bogart JA; Seagren SL; Glicksman A
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3628s-34s. PubMed ID: 16740797
[TBL] [Abstract][Full Text] [Related]
27. Successful gastrointestinal cancer drug development.
Hecht JR
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S24-7. PubMed ID: 17178281
[TBL] [Abstract][Full Text] [Related]
28. [New systemic therapies in oncology].
Zaman K; Ketterer N; Vulliémoz D; Stupp R; Leyvraz S
Rev Med Suisse; 2005 May; 1(20):1361-2, 1364-5. PubMed ID: 15991629
[TBL] [Abstract][Full Text] [Related]
29. Clinical trials and biomarker development with molecularly targeted agents and radiotherapy.
Dhani N; Siu LL
Cancer Metastasis Rev; 2008 Sep; 27(3):339-49. PubMed ID: 18379730
[TBL] [Abstract][Full Text] [Related]
30. Congestive heart failure in pediatric patients.
Kay JD; Colan SD; Graham TP
Am Heart J; 2001 Nov; 142(5):923-8. PubMed ID: 11685182
[No Abstract] [Full Text] [Related]
31. New therapeutic targets for the treatment of high-risk neuroblastoma.
Wagner LM; Danks MK
J Cell Biochem; 2009 May; 107(1):46-57. PubMed ID: 19277986
[TBL] [Abstract][Full Text] [Related]
32. The march toward rational therapeutics in children.
Gorman RL
Pediatr Infect Dis J; 2003 Dec; 22(12):1119-23. PubMed ID: 14688584
[TBL] [Abstract][Full Text] [Related]
33. Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug Development.
Rioux N; Waters NJ
Drug Metab Dispos; 2016 Jul; 44(7):934-43. PubMed ID: 26936973
[TBL] [Abstract][Full Text] [Related]
34. Cancer treatment research: the role of the nurse in clinical trials of cancer therapy.
Hubbard SM
Nurs Clin North Am; 1982 Dec; 17(4):763-83. PubMed ID: 6757874
[No Abstract] [Full Text] [Related]
35. Effective childhood cancer treatment: the impact of large scale clinical trials in Germany and Austria.
Rossig C; Juergens H; Schrappe M; Moericke A; Henze G; von Stackelberg A; Reinhardt D; Burkhardt B; Woessmann W; Zimmermann M; Gadner H; Mann G; Schellong G; Mauz-Koerholz C; Dirksen U; Bielack S; Berthold F; Graf N; Rutkowski S; Calaminus G; Kaatsch P; Creutzig U
Pediatr Blood Cancer; 2013 Oct; 60(10):1574-81. PubMed ID: 23737479
[TBL] [Abstract][Full Text] [Related]
36. Evolving paradigms for new agent development in pediatric oncology.
Flynn A; Fox E
Curr Opin Pediatr; 2018 Feb; 30(1):10-16. PubMed ID: 29176356
[TBL] [Abstract][Full Text] [Related]
37. Developmental therapeutics in childhood cancer. A perspective from the Children's Oncology Group and the US Food and Drug Administration.
Bernstein ML; Reaman GH; Hirschfeld S
Hematol Oncol Clin North Am; 2001 Aug; 15(4):631-55. PubMed ID: 11676277
[TBL] [Abstract][Full Text] [Related]
38. A strategy for controlling potential interactions between natural health products and chemotherapy: a review in pediatric oncology.
Seely D; Stempak D; Baruchel S
J Pediatr Hematol Oncol; 2007 Jan; 29(1):32-47. PubMed ID: 17230065
[TBL] [Abstract][Full Text] [Related]
39. Antineoplastic drug monitoring.
Henner WD
Clin Lab Med; 1987 Sep; 7(3):625-39. PubMed ID: 3308299
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of tumor size response metrics to predict survival in oncology clinical trials.
Bruno R; Mercier F; Claret L
Clin Pharmacol Ther; 2014 Apr; 95(4):386-93. PubMed ID: 24419563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
